Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESTART-Fr: Antiplatelets after Intracerebral Hemorrhage
NCT02966119Phase 3Terminated
- Sponsor
- CHU de Lille
- Start
- Dec 2016
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin, clopidogrel and dipyridamole in vaso-occlusive crisis (VOC) (2 arms), sponsored by CHU de Lille. Primary endpoint: Number of patients with symptomatic intracerebral hemorrhage at 1 year. Started Dec 2016; status: terminated.
02
Drugs
aspirinclopidogreldipyridamole
03
Conditions
vaso-occlusive crisis (VOC)
Beyond the preview
Go deeper on NCT02966119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02966119.